These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2524847)

  • 21. Syntheses and photosensitizing activity of porphyrins joined with ester linkages.
    Pandey RK; Dougherty TJ
    Cancer Res; 1989 Apr; 49(8):2042-7. PubMed ID: 2522815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy: principles and urologic applications.
    Manyak MJ
    Semin Urol; 1991 Aug; 9(3):192-202. PubMed ID: 1835115
    [No Abstract]   [Full Text] [Related]  

  • 23. Photosensitization of malignant tumors.
    Dougherty TJ
    Semin Surg Oncol; 1986; 2(1):24-37. PubMed ID: 2946066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice.
    Nelson JS; McCullough JL; Berns MW
    J Natl Cancer Inst; 1988 Mar; 80(1):56-60. PubMed ID: 2963136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay.
    Winther J
    Br J Cancer; 1989 Jun; 59(6):869-72. PubMed ID: 2525401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size-dependent resistance of human tumour spheroids to photodynamic treatment.
    West CM
    Br J Cancer; 1989 Apr; 59(4):510-4. PubMed ID: 2523722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phototherapy of bladder cancer: dose/effect relationships.
    Haas GP; Shumaker BP; Hetzel FW; Bobrowski R; Lutz MD; Tilley B; Cerny JC
    J Urol; 1986 Aug; 136(2):525-8. PubMed ID: 2942706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components.
    Nelson JS; Wright WH; Berns MW
    J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy of murine skin tumors using Photofrin-II.
    Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
    Evensen JF; Sommer S; Rimington C; Moan J
    Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical test for in vitro evaluation of photosensitization: assessment with hematoporphyrin derivative (HPD).
    Croisy A; Carrez D; Zilberfarb D
    Cytotechnology; 1990 Mar; 3(2):171-8. PubMed ID: 1368556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro photodynamic treatment of normal and human papilloma virus-transfected keratinocytes with photofrin II and red light.
    Bernstein EF; Glass JM; DeGraff WG; Schlegel R; Black C; Fisher JM; Cook SN; Glatstein E; Russo A; Mitchell JB
    Arch Dermatol; 1991 May; 127(5):683-7. PubMed ID: 1850973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization and photosensitization of murine tumors in vivo and in vitro by a chlorin-porphyrin ester.
    Kessel D
    Cancer Res; 1986 May; 46(5):2248-51. PubMed ID: 3697968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor.
    Peng Q; Moan J; Kongshaug M; Evensen JF; Anholt H; Rimington C
    Int J Cancer; 1991 May; 48(2):258-64. PubMed ID: 1826901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy of experimental intraocular retinoblastomas--dose-response relationships to light energy and photofrin II.
    Winther J; Overgaard J
    Acta Ophthalmol (Copenh); 1989 Feb; 67(1):44-50. PubMed ID: 2528265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma.
    Lam S; Kostashuk EC; Coy EP; Laukkanen E; LeRiche JC; Mueller HA; Szasz IJ
    Photochem Photobiol; 1987 Nov; 46(5):893-7. PubMed ID: 2450381
    [No Abstract]   [Full Text] [Related]  

  • 37. P.D.T.--destroying malignant cells with laser beams.
    Tootla J; Easterling A
    Nursing; 1989 Nov; 19(11):48-9. PubMed ID: 2531308
    [No Abstract]   [Full Text] [Related]  

  • 38. Carrier thiols are targets of Photofrin II photosensitization of isolated rat liver mitochondria.
    Atlante A; Passarella S; Quagliariello E; Moreno G; Salet C
    J Photochem Photobiol B; 1990 Sep; 7(1):21-32. PubMed ID: 2148348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spectral properties of new photosensitizers for photodynamic diagnosis and therapy].
    Li BH; Xie SS; Lu ZK
    Guang Pu Xue Yu Guang Pu Fen Xi; 2002 Dec; 22(6):902-4. PubMed ID: 12914159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of short-term versus long-term exposures to Photofrin II in killing light-activated tumor cells.
    Chapman JD; Stobbe CC; Arnfield MR; Santus R; McPhee MS
    Radiat Res; 1991 Oct; 128(1):82-9. PubMed ID: 1833785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.